Related references
Note: Only part of the references are listed.Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non-ST-elevation acute coronary syndrome
Kai C. Wollert et al.
CIRCULATION (2007)
Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure
Tibor Kempf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome
Kai C. Wollert et al.
CIRCULATION (2007)
Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay
Tibor Kempf et al.
CLINICAL CHEMISTRY (2007)
Association of atrial natriuretic peptide and type A natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension
Speranza Rubattu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer
Asne R. Bauskin et al.
CANCER RESEARCH (2006)
Recommendations for chamber quantification
Roberto M. Lang et al.
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY (2006)
The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury
T Kempf et al.
CIRCULATION RESEARCH (2006)
GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation
J Xu et al.
CIRCULATION RESEARCH (2006)
A haplotype map of the human genome
D Altshuler et al.
NATURE (2005)
MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes
VD Marinescu et al.
BMC BIOINFORMATICS (2005)
Population stratification and spurious allelic association
LR Cardon et al.
LANCET (2003)
Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study
DA Brown et al.
LANCET (2002)
Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53
SJ Baek et al.
CARCINOGENESIS (2002)
Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter - Basal transcription is mediated by Sp1 and Sp3
SJ Baek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Prognostic implications of left ventricular hypertrophy
BA Vakili et al.
AMERICAN HEART JOURNAL (2001)
Placental transforming growth factor-β is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression
PX Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart -: Cross-talk between cardiac hypertrophic signaling pathways
LJ De Windt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
PTCF-β, a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway
MJ Tan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
